- Home
- WOLF vs LENZ Comparison
WOLF vs LENZ Comparison
Compare WOLF & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WOLF | LENZ |
|---|---|---|
| Founded | 1987 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 838.3M | 852.0M |
| IPO Year | 1993 | 2021 |
Fundamental Metrics
Financial Performance| Metric | WOLF | LENZ |
|---|---|---|
| Price | $21.34 | $27.30 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | $10.50 | ★ $56.25 |
| AVG Volume (30 Days) | ★ 1.8M | 1.2M |
| Earning Date | 10-29-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $759,700,000.00 | $17,500,000.00 |
| Revenue This Year | $16.42 | N/A |
| Revenue Next Year | N/A | $285.82 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.05 | $16.54 |
| 52 Week High | $36.60 | $50.40 |
Technical Indicators
Market Signals| Indicator | WOLF | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 53.22 | 43.00 |
| Support Level | $16.47 | $27.44 |
| Resistance Level | $23.12 | $32.13 |
| Average True Range (ATR) | 1.69 | 2.20 |
| MACD | 0.45 | 0.72 |
| Stochastic Oscillator | 75.46 | 37.16 |
Price Performance
Historical ComparisonAbout WOLF Wolfspeed Inc.
Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.